energy in essence

We know that partnering and working in collaboration with others are important to accelerate the development of innovative new medicines.

financial support

Khondrion has received funding from a group of strategic supporters including the Dutch Foundations Energy4All, Join4Energy, Road4Energy, Ride4Kids, Tim Foundation, and Zeldzame Ziekten Fonds. Khondrion has also received funding from national and European governments, including from the EU Horizon 2020 SME Instrument Phase 2 program and EFRO (Europees Fonds voor Regionale Ontwikkeling) of the European Union.

EU Horizon 2020 SME grant

In July 2018, Khondrion was awarded €2.3 million from the highly competitive EU Horizon 2020 SME instrument program (grant agreement nr 830115). The Khon2btreat grant is being used for the execution of a Phase IIb dose-finding clinical trial with sonlicromanol in adults with mitochondrial disease

join us

At Khondrion we are pursuing the newest science within our own labs and through collaborations across an extensive clinical and academic network, exploring new avenues of science and sharing knowledge of mitochondrial disease. If you are interested in being part of this, if you’re involved in work that may be relevant to Khondrion or if you would simply like to learn more about our research, then get in touch.

meet our partners